Gastroparesis Diagnostic Study of Choice: Difference between revisions

Jump to navigation Jump to search
 
Line 12: Line 12:
**[[Stomach|Gastric]] retention of 60% at 2 hours (greater accuracy for detecting accelerated [[Stomach|gastric]] emptying)
**[[Stomach|Gastric]] retention of 60% at 2 hours (greater accuracy for detecting accelerated [[Stomach|gastric]] emptying)
**[[Stomach|Gastric]] retention of 10% at 4 hours (higher accuracy for detecting slow [[Stomach|gastric]] emptying)
**[[Stomach|Gastric]] retention of 10% at 4 hours (higher accuracy for detecting slow [[Stomach|gastric]] emptying)
*Factors that might affect on the results of [[Stomach|gastric]] emptying studies include:
**[[Medication|Medications]] that slow down gastric emptying:
***[[Anticholinergic|Anticholinergics]]
***[[Tricyclic antidepressant|Tricyclic antidepressants]]
***[[Narcotic|Narcotic analgesics]]
***[[Adrenergic agonist|Adrenergic agents]]
**[[Tobacco smoking]]
**[[Hyperglycemia]]
*The advantages of [[Stomach|gastric]] emptying scintigraphy include:
*The advantages of [[Stomach|gastric]] emptying scintigraphy include:
**Noninvasive
**Noninvasive

Latest revision as of 16:00, 20 February 2018

Gastroparesis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastroparesis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastroparesis Diagnostic Study of Choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastroparesis Diagnostic Study of Choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastroparesis Diagnostic Study of Choice

CDC on Gastroparesis Diagnostic Study of Choice

Gastroparesis Diagnostic Study of Choice in the news

Blogs on Gastroparesis Diagnostic Study of Choice

Directions to Hospitals Treating Gastroparesis

Risk calculators and risk factors for Gastroparesis Diagnostic Study of Choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]; Madhu Sigdel M.B.B.S.[3]

Overview

Gastric emptying scintigraphy is considered a gold standard diagnostic test for gastroparesis. Delayed gastric emptying is confirmed by 10% gastric retention at 4 hours. Factors that affect the results of this test include medicationstobacco smoking, and hyperglycemia.

Diagnostic Study of Choice

References

  1. Tang, Derek M.; Friedenberg, Frank K. (2011). "Gastroparesis: Approach, Diagnostic Evaluation, and Management". Disease-a-Month. 57 (2): 74–101. doi:10.1016/j.disamonth.2010.12.007. ISSN 0011-5029.
  2. Koch, Kenneth L.; Calles-Escandón, Jorge (2015). "Diabetic Gastroparesis". Gastroenterology Clinics of North America. 44 (1): 39–57. doi:10.1016/j.gtc.2014.11.005. ISSN 0889-8553.
  3. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH; et al. (2008). "Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine". Am J Gastroenterol. 103 (3): 753–63. doi:10.1111/j.1572-0241.2007.01636.x. PMID 18028513.
  4. Waseem S, Moshiree B, Draganov PV (2009). "Gastroparesis: current diagnostic challenges and management considerations". World J Gastroenterol. 15 (1): 25–37. PMC 2653292. PMID 19115465.

Template:WH Template:WS